Comparison between Dr Lalchandani Labs IPO and Indo US Bio-Tech IPO.
Dr Lalchandani Labs IPO is a SME Fixed Price IPO proposed to list at BSE SME while Indo US Bio-Tech IPO is a SME Fixed Price proposed to list at BSE SME.
| Dr Lalchandani Labs IPO | Indo US Bio-Tech IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Navigant Corporate Advisors Ltd. | Swastika Investmart Ltd. |
| Registrar | Cameo Corporate Services Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | NNM Securities Pvt.Ltd. | Beeline Broking Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Dr Lalchandani Labs IPO is up to ₹3.98 Cr whereas the issue size of the Indo US Bio-Tech IPO is up to ₹6.92 Cr. The final issue price of Dr Lalchandani Labs IPO is ₹30.00 per share and of Indo US Bio-Tech IPO is ₹51.00 per share.
| Dr Lalchandani Labs IPO | Indo US Bio-Tech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹30.00 per share | ₹51.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 4000 shares | 2000 shares |
| Fresh Issue Size | 13,28,000 shares | 13,56,000 shares |
| Fresh Issue Size (Amount) | up to ₹3.98 Cr | up to ₹6.92 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 13,28,000 shares | 13,56,000 shares |
| Issue Size Total (Amount) | up to ₹3.98 Cr | up to ₹6.92 Cr |
Dr Lalchandani Labs IPO opens on Apr 25, 2018, while Indo US Bio-Tech IPO opens on Apr 30, 2018. The closing date of Dr Lalchandani Labs IPO and Indo US Bio-Tech IPO is Apr 27, 2018, and May 03, 2018, respectively.
| Dr Lalchandani Labs IPO | Indo US Bio-Tech IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Apr 25, 2018 | Apr 30, 2018 |
| Issue Close | Apr 27, 2018 | May 03, 2018 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | May 09, 2018 | May 11, 2018 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Dr Lalchandani Labs IPO P/E ratio is , as compared to Indo US Bio-Tech IPO P/E ratio of .
| Dr Lalchandani Labs IPO | Indo US Bio-Tech IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹13.00 Cr. | ₹24.76 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Dr Lalchandani Labs IPO Retail Individual Investors (RII) are offered 6,64,000 shares while in Indo US Bio-Tech IPO retail investors are offered 6,64,000 shares. Qualified Institutional Buyers (QIB) are offered in Dr Lalchandani Labs IPO and in Indo US Bio-Tech IPO.
| Dr Lalchandani Labs IPO | Indo US Bio-Tech IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 72,000 shares | 74,000 shares |
| QIB | ||
| NII | 6,64,000 shares | 6,78,000 shares |
| RII | 6,64,000 shares | 6,78,000 shares |
| Employee | ||
| Others | ||
| Total | 13,28,000 shares | 13,56,000 shares |
Dr Lalchandani Labs IPO subscribed 4.63x in total, whereas Indo US Bio-Tech IPO subscribed 19.69x.
| Dr Lalchandani Labs IPO | Indo US Bio-Tech IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 3.13x | 19.52x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 6.13x | 19.87x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.63x | 19.69x |
